Viropro's receivables is $83K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Viropro (VPRO) currently reports a receivables of $83K as of September 2011. That compares with $140K in the prior-year period — down 40.3% year over year. Use the charts on this page to explore Viropro's receivables history and peer comparisons.
Viropro's receivables decreased from $140K to $83K — a 40.3% year-over-year decrease (period ending September 2011). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Viropro reported $83K in receivables as of September 2011. That compares with $140K in the prior-year period — down 40.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current receivables of $83K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Viropro, and consider following VPRO for alerts when major investors trade the stock.
Viropro is classified in the Healthcare sector. On receivables, it currently shows $83K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VPRO with unrelated industries.